Praxis Precision Medicines

PRAX52

$54.02arrow_drop_down8.50%-$5.02

PRAX52

$54.02

arrow_drop_down8.50%-$5.02

Performance History

Key Stats
Open	$58.70
Prev. Close	$59.04
EPS	-5.44
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-

PE Ratio	-

	LOW	HIGH
Day Range	53.85	59.10
52 Week Range	0.86	67.21

Ratios







EPS	-5.44

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Praxis Precision Medicines (PRAX)

Praxis Precision Medicines Inc (PRAX) is a biopharmaceutical company focused on developing and commercializing therapies for patients with central nervous system (CNS) disorders. The company is dedicated to discovering and developing targeted therapies that address the underlying genetic drivers of these disorders. With a deep understanding of the biology of CNS disorders, Praxis Precision Medicines is working towards improving the lives of patients suffering from debilitating conditions.

As of the latest available data, the stock price history of Praxis Precision Medicines Inc (PRAX) shows a positive trend. The stock has experienced a steady increase over the past year, reflecting investor confidence in the company's potential. This positive performance can be attributed to the company's strong pipeline of innovative CNS therapies addressing high unmet medical needs.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Mr. Marcio Souza M.B.A.
Headquarters: Boston
Employees: 109
Exchange: NASDAQ

add Praxis Precision Medicines to watchlist

Keep an eye on Praxis Precision Medicines

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Praxis Precision Medicines 's (PRAX) price per share?

The current price per share for Praxis Precision Medicines (PRAX) is $54.02. The stock has seen a price change of -$5.02 recently, indicating a -8.5% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Praxis Precision Medicines (PRAX)?

For Praxis Precision Medicines (PRAX), the 52-week high is $67.21, which is 24.42% from the current price. The 52-week low is $0.87, the current price is 6.13K% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Praxis Precision Medicines (PRAX) a growth stock?

Praxis Precision Medicines (PRAX) has shown an average price growth of 0.41% over the past three years. It has received a score of 100 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Praxis Precision Medicines as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Praxis Precision Medicines (PRAX) stock price performance year to date (YTD)?

As of the latest data, Praxis Precision Medicines (PRAX) has a year-to-date price change of 158.47%. Over the past month, the stock has experienced a price change of -2.12%. Over the last three months, the change has been 23.25%. Over the past six months, the figure is -7.12%.

help

Is Praxis Precision Medicines (PRAX) a profitable company?

Praxis Precision Medicines (PRAX) has a net income of -$123.28M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 82.35% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -10.5K% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $2.45M, with a revenue growth rate of 67.14%, providing insight into the company's sales performance and growth. The gross profit is $2.02M. Operating income is noted at -$126.37M. Furthermore, the EBITDA is -$132.26M.

help

What is the market capitalization of Praxis Precision Medicines (PRAX)?

Praxis Precision Medicines (PRAX) has a market capitalization of $1.05B. The average daily trading volume is 279.33K, indicating the stock's liquidity and investor engagement.